Milestone Pharmaceuticals Inc
Pharmaceuticals
Milestone Pharmaceuticals Inc (MIST) Stock News
The latest MIST headlines and market coverage — 5 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
MISTR to Fund 2 Million Free HIV & Hepatitis C Tests and Help States Save Hundreds of Millions in ADAP Costs
MISTR, a telehealth platform for sexual health, announced a national commitment to provide 2 million free HIV and Hepatitis C tests by end of 2027 and introduced a partnership model to help states save hundreds of millions in AIDS Drug Assistance Program (ADAP) costs. The company will provide free PrEP to those testing negative for HIV and connect those testing positive to long-term care at no cost to patients or states.
- GlobeNewswire Inc.·
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Priority Technology Holdings, Inc. (Nasdaq – PRTH), MISTRAS Group, Inc. (NYSE – MG), The Baldwin Group, Inc. (Nasdaq – BWIN), Utz Brands, Inc. (NYSE – UTZ)
Law firm Brodsky & Smith announced investigations into four merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and pay fair value to shareholders. The investigations involve Priority Technology Holdings ($8.05/share), MISTRAS Group ($20.35/share), The Baldwin Group ($32.50/share), and Utz Brands ($14.25/share).
- GlobeNewswire Inc.·
MADONNA: CLUB CONFESSIONS AMSTERDAM WITH MISTR
Madonna performed at CLUB CONFESSIONS presented by MISTR during WorldPride Amsterdam on August 4, 2026, surprising fans with a special appearance by Kylie Minogue. The pair debuted a new version of 'Love Sensation' and performed 'Sorry' for the first time in over two decades. The event highlighted Madonna's continued support for the LGBTQ+ community and MISTR's free telemedicine platform offering HIV prevention and sexual healthcare services.
- GlobeNewswire Inc.·
MADONNA: CLUB CONFESSIONS NYC WITH MISTR
Madonna returned to New York City to celebrate her No.1 album Confessions II through CLUB CONFESSIONS, an immersive nightlife experience presented in partnership with MISTR, a telemedicine platform providing free HIV prevention and sexual healthcare services. The event, held at Knockdown Center, featured performances by Stuart Price, Honey Dijon, and other artists, drawing celebrities from music, fashion, and entertainment while raising awareness for LGBTQ+ health initiatives.
- GlobeNewswire Inc.·
Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis
Avalyn Pharma announced completion of target enrollment of 375 patients in the Phase 2b MIST clinical trial of AP01 (inhaled pirfenidone) for progressive pulmonary fibrosis. The global, randomized, double-blinded, placebo-controlled trial is evaluating two doses of AP01 against placebo, with primary endpoint measuring change in lung function at 52 weeks. Topline data is expected in the second half of 2027.